US Drug Recall Register
Class II · Moderate risk Terminated Initiated Dec 28, 2022 (4 years ago)

Rasagiline Mesylate Tablets 1 mg; 30 tablets in HDPE bottle; Rx only; NDC 67877-260-30…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of Foreign Substance- A complaint was received of black spots/shiny metallic speck on the tablets.

What was recalled

Rasagiline Mesylate Tablets 1 mg; 30 tablets in HDPE bottle; Rx only; NDC 67877-260-30; Manufactured by Alkem Laboratories Ltd., India; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054

Recalling firm
Ascend Laboratories, LLC
NDC code
67877-260-30
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0159-2023

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Rasagiline recalls

See all